“Safe Use of Interleukin-17 Inhibitors for Psoriasis and Psoriatic Arthritis in Two Patients With a History of Lymphoproliferative Disease”. 2020. SKIN The Journal of Cutaneous Medicine 4 (3): 256-59. https://doi.org/10.25251/skin.4.3.7.